2.4.0.80010 - Disclosure - Non-Controlling Interest In Subsidiariestruefalsefalse1false falsefalseFrom2013-01-01to2013-06-30http://www.sec.gov/CIK0001341768duration2013-01-01T00:00:002013-06-30T00:00:001true 1DEEL_NotesToFinancialStatementsAbstractDEEL_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Notes to Financial Statements2false 2DEEL_NoncontrollingInterestInSubsidiariesTextBlockDEEL_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00The Company owns 4,500 shares of common stock of the 5,357 shares outstanding in Diagnostic Nano Applications Corporation (DNA) for a 78.4% share. DNA is a discontinued operation.   On November 4, 2011, the Company executed an Asset Acquisition Agreement exchanging its remaining 30.01% interest in OLFactor Laboratories, Inc. and 50.0% interest in Nano Engineered Applications, Inc. for 10,000,000 shares of Innovation Economy Corp. (IEC), an affiliated Company. Currently, the shares of Innovation Economy Corp. are not tradable.   In a Restricted Stock Purchase Right Agreement dated November 4, 2011, DADG has the right on a quarterly basis over the next year to purchase shares that would allow it to maintain a 10% ownership interest in IEC. The 10 million shares the Company owns represents a 12.24% ownership interest in IEC.falsefalsefalsenonnum:textBlockItemTypenaCustom Element.No definition available.false0Note 4. NON-CONTROLLING INTEREST IN SUBSIDIARIESfalseNon-Controlling Interest In SubsidiariesUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://dealadaygroup.com/role/Non-ControllingInterestInSubsidiaries12